Dimensional Fund Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.9M | Sell |
648,336
-123,967
| -16% | -$3.43M | ﹤0.01% | 2022 |
|
2025
Q1 | $17.2M | Buy |
772,303
+696
| +0.1% | +$15.5K | ﹤0.01% | 2011 |
|
2024
Q4 | $15.3M | Buy |
771,607
+29,300
| +4% | +$580K | ﹤0.01% | 2125 |
|
2024
Q3 | $18.6M | Buy |
742,307
+78,267
| +12% | +$1.96M | ﹤0.01% | 2036 |
|
2024
Q2 | $12.4M | Buy |
664,040
+157,741
| +31% | +$2.95M | ﹤0.01% | 2166 |
|
2024
Q1 | $9.99M | Buy |
506,299
+156,546
| +45% | +$3.09M | ﹤0.01% | 2310 |
|
2023
Q4 | $6.13M | Sell |
349,753
-23,968
| -6% | -$420K | ﹤0.01% | 2502 |
|
2023
Q3 | $6.49M | Sell |
373,721
-1,388
| -0.4% | -$24.1K | ﹤0.01% | 2439 |
|
2023
Q2 | $5.28M | Sell |
375,109
-2,149
| -0.6% | -$30.3K | ﹤0.01% | 2505 |
|
2023
Q1 | $4.06M | Sell |
377,258
-15,533
| -4% | -$167K | ﹤0.01% | 2545 |
|
2022
Q4 | $5.88K | Sell |
392,791
-675
| -0.2% | -$10 | ﹤0.01% | 2395 |
|
2022
Q3 | $5.05M | Sell |
393,466
-13,681
| -3% | -$176K | ﹤0.01% | 2422 |
|
2022
Q2 | $3.95M | Buy |
407,147
+46,207
| +13% | +$448K | ﹤0.01% | 2517 |
|
2022
Q1 | $3.59M | Buy |
360,940
+201,622
| +127% | +$2M | ﹤0.01% | 2635 |
|
2021
Q4 | $1.88M | Buy |
159,318
+25,031
| +19% | +$295K | ﹤0.01% | 2862 |
|
2021
Q3 | $1.53M | Sell |
134,287
-193,927
| -59% | -$2.21M | ﹤0.01% | 2925 |
|
2021
Q2 | $4.57M | Buy |
328,214
+90,167
| +38% | +$1.26M | ﹤0.01% | 2638 |
|
2021
Q1 | $4.41M | Buy |
238,047
+163,191
| +218% | +$3.02M | ﹤0.01% | 2625 |
|
2020
Q4 | $1.32M | Buy |
74,856
+4,609
| +7% | +$81.5K | ﹤0.01% | 2917 |
|
2020
Q3 | $1.08M | Buy |
70,247
+5,167
| +8% | +$79.1K | ﹤0.01% | 2911 |
|
2020
Q2 | $1.66M | Sell |
65,080
-791
| -1% | -$20.2K | ﹤0.01% | 2816 |
|
2020
Q1 | $1.02M | Buy |
65,871
+39,181
| +147% | +$604K | ﹤0.01% | 2887 |
|
2019
Q4 | $295K | Buy |
+26,690
| New | +$295K | ﹤0.01% | 3215 |
|